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Introduction

High-serum cholesterol levels, hypertension and smoking are classical risk factors for atherosclerosis and coronary heart disease (CHD). In addition, age, sex, obesity, diabetes, high-serum triglyceride and low-high-density lipoprotein (HDL) levels predispose to CHD. Accumulating evidence also suggests that acute and chronic infections of bacterial origin, including respiratory pathogens, for example Chlamydia pneumoniae (Cpn) and periodontal pathogens, for example Aggregatibacter (formerly Actinobacillus
, are associated with an increased risk for cardiovascular disease [1] [2] [3] [4] [5] [6] . Indeed, recent studies have shown a diverse bacterial signature with DNA from over 50 different bacterial species present in atherosclerotic lesions of patients with CHD, further suggesting a role for bacterial infection in the pathogenesis of atherosclerosis [7] [8] [9] . Moreover, the vulnerability of the arterial wall to bacterial infections is augmented in the presence of other cardiovascular risk factors, such as hypercholesterolaemia, suggesting that atherosclerosis per se may predispose to the development of chronic infections [10] . In particular, a dysfunctional 'leaky' endothelium with increased expression of leucocyte adhesion molecules may actively promote the infiltration of bacteria-containing monocytes from the circulation into the atherosclerotic lesions [8] . Alternatively, the atheromas may simply act as mechanical sieves that collect free bacteria [7] or bacterial products associated with pro-atherogenic serum lipoproteins, such as VLDL and low-density lipoprotein (LDL) [11] , from the circulation. However [12, 13] . They are typically localized at host-environment interfaces, such as in perivascular areas where they encounter both antigens and invading pathogens, which allows them to exert a unique sentinel role in host defence [14] . [15] . Protein L from Peptostreptococcus magnus has been shown to activate human cardiac mast cells [15] , and mast cells have also been shown to engulf Escherichia coli [16] , and to protect mice from Mycoplasma pneumoniae infection [17] . [18, 19] . Thus, mast cell activation during acute bacterial infections is clearly a matter of homeostatic inflammation.
Accordingly, mast cells have been shown to recognize and respond to many different pathogens and their products in various diseases. Staphylococcus aureus -derived protein A, which is capable of inducing acute peritonitis, was the first pathogen-associated immunoglobulin-binding protein that was shown to activate mast cells
Moreover, studies in animal models have indicated that mast cells play a protective role in host defence against bacteria by producing tumour necrosis factor ␣ (TNF-␣), mainly as a result of toll-like receptor 4 (TLR4)-or CD48-mediated activation
Mast cells are also present in increased numbers in atherosclerotic plaques and they have been shown to participate both in early and late events in the pathogenesis of atherosclerosis and myocardial infarction [20] [21] [22] [23] . Since plaque mast cells are an ample source of multi-functional cytokines with inflammatory properties [24, 25] , they may also modulate the local immune system by releasing such cytokines in both quantitatively and qualitatively different ways [13] . Despite [26] . (Fig. 4) . Recent observations have indicated that several types of bacteria are present in human atherosclerotic lesions [8] [48] and TLR4 [49] 
Materials and methods
Mast cell culture
Infection of mast cells with bacteria
Real-time PCR
Determination of cytokine and chemokine levels
the secretion of TNF-␣ was delayed after bacterial inoculation and was found to be increased only after 6 hrs of incubation, corresponding to the delay in the mRNA response to Cpn. There was no measurable secretion of IL-10 or TGF-␤1 (data not shown). The responses of mRNA and protein secretion to the inoculation of Aa strains were also studied and were found to be similar to those found for Cpn (data not shown). The bacterial infection also induced a release of histamine indicating mast cell degranulation, but it did not induce mast cell death, when measured as release of LDH (data not shown).
Fig. 1 Effect of pro-atherogenic bacteria on human mast cell cytokine expression. Cultured human mast cells were infected with Aggregatibacter actinomycetemcomitans (Aa) strains AT445b and JP2 or Chlamydia pneumoniae (Cpn) in a cell-to-bacteria ratio of 1:10 and incubated for 6 hrs. mRNA expressions for IL-8 (A), TNF-␣ (B) and monocyte chemoattractant protein-1 (MCP-1) (C) were analysed by real-time PCR using TaqMan chemistry. Data are normalized to ␤-actin and presented as means Ϯ SD.
To estimate the concentration of bacteria required to trigger cytokine release by human mast cells in culture, increasing amounts of bacteria were used to inoculate the cells. Mast cells cocultured with Cpn in a 1:1 cell-to-bacterium ratio already induced a significant expression of TNF-␣ (P ϭ 0.049), IL-8 (P ϭ 0.020) and MCP-1 (P ϭ 0.035) mRNA, and the corresponding ratios of 1:5 and 1:10 still further increased the expression levels of the investigated genes (Fig. 3). To test whether the induction of cytokine mRNA expression and protein secretion by mast cells was dependent on the viability of the bacteria, the pathogens were treated with UV radiation before inoculation, as described in Materials and Methods. Indeed, UV treatment of Cpn inhibited the induction of IL-8, both at the mRNA (P ϭ 0.002) and protein (P ϭ 0.0015) level, revealing that the IL-8 response was dependent on the viability of the bacteria. Similarly, both the synthesis and secretion of TNF-␣ were significantly reduced (P ϭ 0.017 and P ϭ 0.0001, respectively) when the mast cells were inoculated with UV-treated Cpn, as compared to live bacteria (Fig. 4). In contrast, inactivation of Cpn failed to reduce the expression and secretion of MCP-1. Finally, UV-treatment of either strain of Aa had only minor effects on the expression and secretion of cytokines
Since monocyte-derived macrophages is an abundant cell type in atherosclerotic lesions, and also, since a likely route for certain bacteria, such as Cpn, to reach atherosclerotic lesions is via infected circulating monocytes, we next studied the ability of inoculated human monocyte-derived macrophages to activate cocultured human mast cells. As shown in Fig. 5 (parts A and B), Cpn-infected macrophages induced a significant expression of IL-8 (P ϭ 0.0039) and TNF-␣ P ϭ 0.050) mRNA in cocultured human mast cells. To test whether cell-to-cell contact between the two types of cultured cell was necessary for the observed Cpn-dependent induction of cytokines, we next incubated mast cells with preconditioned media obtained from macrophages inoculated with Cpn. Interestingly, mast cells treated with the preconditioned media from Cpn-infected macrophages responded by increasing the expression of IL-8 (P ϭ 0.0040) and TNF-␣ (P ϭ 0.0037) (parts C and D). Thus, inoculation of macrophages with
